Speaking at a webinar on Alzheimer’s organized by EuroPharma president Terry Lemerond, Professor Ralph Martins said the first trial would examine the effect of a bioavailable form of curcumin – the bioactive component in turmeric – on amyloid accumulation in the human brain.
Original post:
... continue reading
Researchers at the University of British Columbia may have discovered that a profusion of blood vessels may explain how Alzheimer’s disease destroys the brain. Although previous Alzheimer’s research concentrated mainly on the death of cells in the walls of blood vessels or in brain tissue, a new study led by ... continue reading
“Chemistry can be very dry.” That comment comes from a second-year chemistry doctoral candidate at Duke University in North Carolina now working with his professor on research that targets metals – copper and zinc – and their relation to Alzheimer’s disease.
See the article here:
... continue reading